News and Announcements
Bioactive Laboratories Closing their Fundraising Round Early
- Published August 06, 2014 5:02PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Bioactive Laboratories, a developer of a world first anti-inflammatory & pain relieving agent that is gentle to the stomach, closes their current fund raising campaign early.
Rick Ferdinands MD describes this fund raising experience: “Bioactive are grateful to the Wholesale Investor team; it’s the most effective platform to meet qualified investors in Australia. We are now able to close this fund raising campaign early and get on with business”.
As there are a number of investors who weren’t aware of the closure, Bioactive Laboratories have extended the deadline to Friday, 22nd August 2014.
As you can imagine with the strong response to the campaign, the company have already commenced the next stages of their strategic plan featuring the TGA registration completion, production trials and further customer engagement.
For those who could not make it to the Melbourne Showcase in July, you can view Rick’s presentation at www.bioactivelab.com.au/news/